Calcimimetics and Bone Mineral Density in Renal Transplant Patients With Persistent Secondary Hyperparathyroidism

Transplantation Proceedings

Volumn 41, Issue 6, 2009, Pages 2144-2147

  Toro Prieto, F J ^a   Bernal Blanco, G ^a   Navarro Garcia M ^a   Cabello Chaves, V ^a   GarciaJimenez R ^a   Pereira Palomo, P ^a   Gentil Govantes, M A ^a  

^a HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; CINACALCET; PARATHYROID HORMONE; PHOSPHORUS;

ARTICLE; BONE DENSITY; BONE MINERAL; CALCIUM BLOOD LEVEL; DRUG EFFICACY; FEMUR NECK; HYPERCALCEMIA; KIDNEY TRANSPLANTATION; PARATHYROID HORMONE BLOOD LEVEL; PHOSPHATE BLOOD LEVEL; PRIORITY JOURNAL; PROSPECTIVE STUDY; SECONDARY HYPERPARATHYROIDISM; SPINE; SPINE RADIOGRAPHY; TREATMENT OUTCOME;

ADULT; AGED; BONE DENSITY; CALCIUM; CERVICAL VERTEBRAE; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERCALCEMIA; HYPERPARATHYROIDISM, SECONDARY; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; NAPHTHALENES; PARATHYROID HORMONE; PROSPECTIVE STUDIES; SPINE;

EID: 68949204950     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2009.06.088     Document Type: Article

References (18)

1. Rojas E., Carlini R.G., Clesca P., et al. The pathogenesis of osteodystrophy after renal transplantation as detected by early alterations in bone remodeling. Kidney Int 63 (2003) 1915
2. Wada M., Furuya Y., Sakiyama J., et al. The calcimimetic compound NPS R-568 suppresses parathyroid cell proliferation in rats with renal insufficiency. Control of parathyroid cell growth via a calcium receptor. J Clin Invest 100 (1997) 2977
3. Mizobuchi M., Hatamura I., and Ogata H. Calcimimetic compound upregulates decreased calcium-sensing receptor expression level in parathyroid glands of rats with chronic renal insufficiency. J Am Soc Nephrol 15 (2004) 2579
4. Block G.A., Martin K.J., de Francisco A.L., et al. Cinacalcet for secondary hyperparathyroidism in patients receiving hemodialysis. N Engl J Med 350 (2004) 1516
5. Lien Y.H.H., Silva A.L., and Whittman D. Effects of cinacalcet on bone mineral density in patients with secondary hyperparathyroidism. Nephrol Dial Transplant 20 (2005) 1232
6. Fleseriu M., and Licata A.A. Failure of successful renal transplant to produce appropriate levels of 1,25-dihydroxyvitamin D. Osteoporos Int 18 (2007) 363
7. Torres A., García S., Gómez A., et al. Treatment with intermittent calcitriol and calcium reduces bone loss after renal transplantation. Kidney Int 65 (2004) 705
8. Leca N., Laftavi M., Gundroo A., et al. Early and severe hyperparathyroidism associated with hypercalcemia after renal transplant treated with cinacalcet. Am J Transplant 6 (2006) 2391
9. Komaba H., and Fukagawa M. Basic and clinical aspects of calcimimetics. Calcimimetics: a promising treatment for persistent hypercalcemia after kidney transplantation. Clin Calcium 18 (2008) 60
10. Srinivas T.R., Schold J.D., Womer K.L., et al. Improvement in hypercalcemia with cinacalcet after kidney transplantation. Clin J Am Soc Nephrol 1 (2006) 323
11. Dong B.J. Cinacalcet: an oral calcimimetic agent for the management of hyperparathyroidism. Clin Ther 27 (2005) 1725
12. Kruse A.E., Eisenberger U., Frey F.J., et al. Effect of cinacalcet cessation in renal transplant recipients with persistent hyperparathyroidism. Nephrol Dial Transplant 22 (2007) 2362
13. Serra A.L., Savoca R., Huber A.R., et al. Effective control of persistent hyperparathyroidism with cinacalcet in renal allograft recipients. Nephrol Dial Transplant 22 (2007) 577
14. Bergua C., Torregrosa J.V., Cofán F., et al. Cinacalcet for the treatment of hypercalcemia in renal transplanted patients with secondary hyperparathyroidism. Transplant Proc 39 (2007) 2254
15. Strippoli G.F.M., Tong A., Palmer S.C., et al. Calcimimetics in secondary hyperparathyroidism in chronic kidney disease patients. Cochrane Library (2008) 2
16. Bergua C., Torregrosa J.V., Fuster D., et al. Effect of cinacalcet on hypercalcemia and bone mineral density in renal transplanted patients with secondary hyperparathyroidism. Transplantation 86 (2008) 413
17. Decleire P.Y., Devogelaer J.P., and Goffin E. Cinacalcet improves bone mineral density in a renal transplant recipient with persistent hyperparathyroidism. Clin Nephrol 69 (2008) 231
18. de Francisco A.L. New strategies for the treatment of hyperparathyroidism incorporating calcimimetics. Expert Opin Pharmacother 9 (2008) 795